Dual GH secretagogue · CJC-1295 + Ipamorelin 10mg
Two complementary growth hormone secretagogues — CJC-1295 and Ipamorelin — working synergistically in a single precision pen.
Modified GHRH peptide supporting sustained growth hormone release signal amplification.
Selective ghrelin mimetic supporting clean pulsatile GH release without cortisol or appetite effects.
CJC-1295 and Ipamorelin are two complementary growth hormone secretagogues that work synergistically. CJC-1295 is a GHRH analogue supporting sustained growth hormone release, while Ipamorelin is a selective GH secretagogue that mimics ghrelin signalling.
The combination creates a dual-action approach to growth hormone support: CJC-1295 provides the sustained baseline signal while Ipamorelin delivers selective pulsatile amplification — without the cortisol or appetite side effects associated with older GH peptides.
The CJIP10 Pen is used as the primary component of the CUTPR Prime Cut Protocol, or as a standalone growth signal pen within a personalised performance programme.
Every Lumeva protocol is manufactured using advanced synthesis techniques within controlled laboratory environments. Carries ≥99.9% purity certification and full batch-specific QA documentation.
Book a consultation to start your CJIP10 Growth Signal Pen protocol under expert guidance.